Jason Kaplan

2.6k total citations · 1 hit paper
61 papers, 1.7k citations indexed

About

Jason Kaplan is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Jason Kaplan has authored 61 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 22 papers in Pathology and Forensic Medicine and 20 papers in Genetics. Recurrent topics in Jason Kaplan's work include Lymphoma Diagnosis and Treatment (16 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Viral-associated cancers and disorders (6 papers). Jason Kaplan is often cited by papers focused on Lymphoma Diagnosis and Treatment (16 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Viral-associated cancers and disorders (6 papers). Jason Kaplan collaborates with scholars based in United States, Japan and Italy. Jason Kaplan's co-authors include Benedito A. Carneiro, Young Kwang Chae, Francis J. Giles, Ricardo Costa, Sachin Gopalkrishna Pai, Sunandana Chandra, Aparna Kalyan, Caio A. Leite, José Maurício Mota and Romualdo Barroso‐Sousa and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jason Kaplan

57 papers receiving 1.7k citations

Hit Papers

Wnt/beta-catenin pathway: modulating anticancer immune re... 2017 2026 2020 2023 2017 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Wnt/beta-catenin pathway: modulating anticancer immune response
    2017 524 citations Sachin Gopalkrishna Pai, Benedito A. Carneiro et al. Journal of Hematology & Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason Kaplan United States 19 774 612 399 286 260 61 1.7k
Angelica Calleri Italy 21 853 1.1× 866 1.4× 524 1.3× 186 0.7× 216 0.8× 46 1.8k
Elena De Mattia Italy 25 725 0.9× 963 1.6× 279 0.7× 200 0.7× 324 1.2× 92 2.0k
Loukas Kaklamanis Greece 26 892 1.2× 375 0.6× 564 1.4× 368 1.3× 147 0.6× 76 1.9k
Frauke Bentzien United States 10 821 1.1× 665 1.1× 298 0.7× 283 1.0× 522 2.0× 12 2.1k
Takanori Goi Japan 26 1.2k 1.6× 712 1.2× 310 0.8× 237 0.8× 207 0.8× 149 2.1k
Yin‐Hsun Feng Taiwan 20 732 0.9× 475 0.8× 476 1.2× 127 0.4× 195 0.8× 69 1.5k
Marco Pizzi Italy 28 910 1.2× 463 0.8× 629 1.6× 354 1.2× 385 1.5× 124 2.2k
Ioannis A. Voutsadakis Canada 27 914 1.2× 1.2k 2.0× 639 1.6× 298 1.0× 474 1.8× 161 2.3k
Byung Woog Kang South Korea 19 468 0.6× 508 0.8× 347 0.9× 239 0.8× 198 0.8× 77 1.2k
Hao‐Wei Teng Taiwan 21 576 0.7× 788 1.3× 270 0.7× 231 0.8× 254 1.0× 73 1.4k

Countries citing papers authored by Jason Kaplan

Since Specialization
Citations

This map shows the geographic impact of Jason Kaplan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Kaplan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Kaplan more than expected).

Fields of papers citing papers by Jason Kaplan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Kaplan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Kaplan. The network helps show where Jason Kaplan may publish in the future.

Co-authorship network of co-authors of Jason Kaplan

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Kaplan. A scholar is included among the top collaborators of Jason Kaplan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Kaplan. Jason Kaplan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maron, Steven B., Keisho Chìn, Fadi S. Braiteh, et al.. (2025). Phase II trial of enfortumab vedotin in patients with previously treated gastric and esophageal cancers. ESMO Open. 10(11). 105806–105806.
2.
3.
4.
Muro, Kei, Keisho Chìn, Steven B. Maron, et al.. (2024). Enfortumab vedotin (EV) in previously treated gastric/esophageal cancers cohorts of EV-202.. Journal of Clinical Oncology. 42(16_suppl). 4046–4046. 2 indexed citations
5.
Swiecicki, Paul, Emrullah Yilmaz, Ari J. Rosenberg, et al.. (2024). Phase II Trial of Enfortumab Vedotin in Patients With Previously Treated Advanced Head and Neck Cancer. Journal of Clinical Oncology. 43(5). 578–588. 9 indexed citations
6.
Muro, Kei, Trevor Feinstein, Joaquina Baranda, et al.. (2024). Enfortumab vedotin (EV) in non-squamous and squamous non–small cell lung cancer (NSCLC) cohorts of EV-202.. Journal of Clinical Oncology. 42(16_suppl). 8585–8585. 2 indexed citations
7.
Karmali, Reem, Jeremy S. Abramson, Deborah M. Stephens, et al.. (2023). Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphoma. Blood Advances. 7(23). 7361–7368. 3 indexed citations
8.
Kaplan, Jason, et al.. (2022). COR TRIATRIATUM DEXTER: A RARE CONGENITAL MALFORMATION FOUND ON TRANSESOPHAGEAL ECHOCARDIOGRAM. Journal of the American College of Cardiology. 79(9). 3167–3167.
9.
10.
11.
Costa, Ricardo, Irene Helenowski, Jonna Peterson, et al.. (2017). Meta-analysis of selected toxicity endpoints of CDK4/6 inhibitors: Palbociclib and ribociclib. The Breast. 35. 1–7. 24 indexed citations
12.
Pai, Sachin Gopalkrishna, Benedito A. Carneiro, José Maurício Mota, et al.. (2017). Wnt/beta-catenin pathway: modulating anticancer immune response. Journal of Hematology & Oncology. 10(1). 101–101. 524 indexed citations breakdown →
13.
Costa, Ricardo, et al.. (2017). A Rare Case of Glioblastoma Multiforme with Osseous Metastases. Case Reports in Oncological Medicine. 2017(1). 2938319–2938319. 11 indexed citations
14.
Kaplan, Jason, Brady L. Stein, Brandon McMahon, Francis J. Giles, & Leonidas C. Platanias. (2016). Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms. EBioMedicine. 3. 17–25. 5 indexed citations
15.
Costa, Ricardo, Francis J. Giles, Benedito A. Carneiro, et al.. (2016). Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives. Drug Design Development and Therapy. 10. 873–873. 35 indexed citations
16.
Carneiro, Benedito A., Jason Kaplan, Jessica K. Altman, Francis J. Giles, & Leonidas C. Platanias. (2015). Targeting mTOR signaling pathways and related negative feedback loops for the treatment of acute myeloid leukemia. Cancer Biology & Therapy. 16(5). 648–656. 32 indexed citations
17.
Carneiro, Benedito A., Jessica K. Altman, Jason Kaplan, et al.. (2015). Targeted therapy of acute myeloid leukemia. Expert Review of Anticancer Therapy. 15(4). 399–413. 12 indexed citations
18.
Kaplan, Jason, et al.. (2015). Blinatumomab for the treatment of acute lymphoblastic leukemia. Investigational New Drugs. 33(6). 1271–1279. 23 indexed citations
19.
Kaplan, Jason, et al.. (1993). Regulation of Epidermal Growth Factor Receptor Expression and Growth by Protein Kinase C and Retinoic Acid in LLC-PK1 Cells. American Journal of Kidney Diseases. 22(6). 858–864. 4 indexed citations
20.
Kaplan, Jason. (1978). Characterization of thymosin-responsive peripheral blood null cells.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 62(11). 1757–61. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angelica Calleri Breakdown of academic impact, for papers by Elena De Mattia Breakdown of academic impact, for papers by Loukas Kaklamanis Breakdown of academic impact, for papers by Frauke Bentzien Breakdown of academic impact, for papers by Takanori Goi Breakdown of academic impact, for papers by Yin‐Hsun Feng Breakdown of academic impact, for papers by Marco Pizzi Breakdown of academic impact, for papers by Ioannis A. Voutsadakis Breakdown of academic impact, for papers by Byung Woog Kang Breakdown of academic impact, for papers by Hao‐Wei Teng
Rankless by CCL
2026